Equities

LifeVantage Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert

LifeVantage Corp

Actions
  • Price (EUR)3.70
  • Today's Change0.20 / 5.71%
  • Shares traded140.00
  • 1 Year change-78.49%
  • Beta0.3681
Data delayed at least 15 minutes, as of Feb 06 2026 07:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

LifeVantage Corporation is an activation company, which is engage in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, weight management products, pre- and pro-biotics, skin and hair care products, and nootropics. The Company’s line of scientifically validated activators includes the flagship Protandim family of products, TrueScience Liquid Collagen, the newest MindBody GLP-1 System, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System , as well as AXIO nootropic energy drink mixes, the full TrueScience line of skin and hair care products, and Petandim, a pet supplement formulated to combat oxidative stress in dogs. It sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand and Singapore.

  • Revenue in USD (TTM)228.88m
  • Net income in USD10.13m
  • Incorporated2018
  • Employees232.00
  • Location
    LifeVantage Corp3300 TRIUMPH BLVD, SUITE 700LEHI 84043United StatesUSA
  • Phone+1 (801) 432-9000
  • Fax+1 (302) 636-5454
  • Websitehttps://www.lifevantage.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
LFVN:NAQ since
announced
Transaction
value
Global Organics Merchants LLCDeal completed03 Sep 202503 Sep 2025Deal completed-62.88%--
Data delayed at least 15 minutes, as of Feb 06 2026 21:00 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.